The Dr. Agarwal’s Health Care Share Price 2030 is set to open for subscription on January 29, 2025, and close on January 31, 2025. With a price band ranging from ₹382 to ₹402 per share, the IPO is expected to raise ₹3,027.26 crores. The shares are proposed to be listed on both the BSE and NSE, with a minimum lot size of 35 shares.
IPO Details
- IPO Opening Date: January 29, 2025
- IPO Closing Date: January 31, 2025
- Listing Date: February 5, 2025
- Price Band: ₹382.00 to ₹402.00 per share
- Lot Size: 35 shares
- Total Issue Size: ₹3,027.26 crores
- Exchange: BSE and NSE
Company Background
Dr. Agarwal’s Health Care Limited is a leading player in the healthcare sector, renowned for its expertise in eye care services. With a vast network of specialty hospitals and clinics, the company has a strong presence across India and internationally. The proceeds from this IPO will be used to expand its healthcare facilities, enhance technological capabilities, and strengthen its financial position.
Objectives of the IPO
- Expansion of Healthcare Facilities: Establishing new specialty hospitals and clinics in key locations.
- Technology Integration: Investing in advanced healthcare technologies to improve service quality.
- Debt Repayment: Reducing financial liabilities to improve profitability.
- Brand Development: Increasing awareness and market penetration in untapped regions.
Financial Performance and Growth Predictions
- Revenue (Last FY): ₹2,150 Crores
- Profit (Last FY): ₹320 Crores
- Year-over-Year Growth: 18%
| Year | Predicted Share Price (₹) |
|---|---|
| 2025 | ₹420 – ₹450 |
| 2026 | ₹480 – ₹520 |
| 2027 | ₹540 – ₹600 |
| 2028 | ₹620 – ₹700 |
| 2029 | ₹750 – ₹850 |
| 2030 | ₹880 – ₹1,000 |
Subscription Details
| Category | Expected Subscription |
|---|---|
| Retail Investors | High |
| Institutional Investors | Strong |
| HNIs | Significant Demand |
Key Growth Factors
- Healthcare Demand: Rising need for specialized eye care services.
- Technology Advancements: Adoption of AI and robotic-assisted surgeries.
- International Expansion: Entry into new markets globally.
- Market Leadership: Established reputation and brand equity in the healthcare sector.
Conclusion
The Dr. Agarwal’s Health Care Limited IPO represents a significant opportunity for investors in the healthcare domain. The company’s solid track record, ambitious growth plans, and focus on innovation position it well for long-term success. Investors should carefully evaluate the offering in line with their financial goals and risk tolerance.